AzTrials
AzTrials

Zumba ExerciseNCT07423624

Effect of 12 Weeks of Zumba Combined With Halotherapy on Body Composition, Respiratory, and Cardiorespiratory Parameters in Sedentary Older Adults

A study testing Zumba + Halotherapy Group in people with Zumba Exercise and Halotherapy, run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial examined the effects of a 12-week Zumba exercise program combined with halotherapy on body composition, aerobic capacity, and physical fitness parameters in adult women. Participants were randomly assigned to a Zumba plus halotherapy group or a control group. Read more about this study

Who is it for?
Ages 55 to 80 years
Conditions the study is for
Zumba Exercise, Halotherapy, Physical Fitness
What is being tested?
Zumba + Halotherapy Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
5 May 2024to 20 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Female participants aged [55-80] years
  • Sedentary or recreationally active
  • No regular exercise participation in the previous 6 months

Who cannot join

  • Cardiovascular, respiratory, or musculoskeletal disorders
  • Pregnancy
  • Participation in structured exercise programs during the study period

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gumushane Univetsity

    Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, 29600

Other trials in Turkey (Türkiye)

About this study

This randomized controlled trial examined the effects of a 12-week Zumba exercise program combined with halotherapy on body composition, aerobic capacity, and physical fitness parameters in adult women. Participants were randomly assigned to a Zumba plus halotherapy group or a control group. Physical fitness tests and body composition measurements were performed before and after the intervention.

Read the detailed description

Zumba is a popular aerobic dance-based exercise known to improve cardiovascular fitness and body composition. Halotherapy, involving exposure to salt-enriched air, has been suggested to support respiratory function and overall well-being. However, evidence regarding the combined effects of Zumba training and halotherapy is limited.

This study aimed to investigate whether combining halotherapy with regular Zumba training would provide additional benefits compared to no intervention.

Being tested
Zumba + Halotherapy Group, Control
Keywords
physical therapy, sedentary older adults, aerobic exercise, Zumba, halotherapy, complementary therapy, pulmonary function

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Zumba + Halotherapy GroupOther

    Participants performed Zumba training sessions [haftada X gün, seans süresi] for 12 weeks. Each session was followed by halotherapy exposure in a salt room environment.

  • ControlOther

    Participants maintained their usual daily activities without structured exercise or halotherapy.

Study groups in NCT07423624
Study groupRoleWhat they receive
Zumba + Halotherapy GroupExperimentalParticipants performed Zumba training sessions [haftada X gün, seans süresi] for 12 weeks. Each session was followed by halotherapy exposure in a salt room environment.
Receives: Other: Zumba + Halotherapy Group; Other: Control
CONTROLNo interventionParticipants maintained their usual daily activities without structured exercise or halotherapy.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Body Composition

    Parameter: Body weight

    Measured: 12 week

  2. Aerobic Capacity

    Measured by [ 6-minute walk test / VO₂max estimation]

    Measured: 12 weeks

  3. Body Composition

    Parameter: BMI

    Measured: 12 week

Secondary outcomes (3)
  1. Handgrip strength

    Test: Handgrip strength

    Measured: 12 weeks

  2. Flexibility

    Test: Sit-and-reach

    Measured: 12 weeks

  3. Balance

    Test: Flamingo or similar balance test

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2026
  2. Study start5 May 2024
  3. Primary completion15 Aug 2024
  4. Study completion20 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07423624
Sponsor's protocol ID
2025/0471
Status last verified
Mar 2026
First submitted
6 Feb 2026
Last updated
17 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The individual participant data collected in this study will not be shared with other researchers due to the need to protect participant confidentiality and the lack of permission for data sharing within the scope of informed consent.

Questions about this trial

What is this clinical trial studying?

A study testing Zumba + Halotherapy Group in people with Zumba Exercise and Halotherapy, run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Body Composition (time frame: 12 week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in